{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:54:48Z","timestamp":1768449288700,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009078","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:00:00Z","timestamp":1347408000000}}],"reference-count":58,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009078.pub2","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T22:38:34Z","timestamp":1346798314000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Topical cyclosporine for atopic keratoconjunctivitis"],"prefix":"10.1002","volume":"2012","author":[{"given":"Julio J","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"first","affiliation":[{"name":"Hospital Ram\u00f3n y Cajal; Department of Ophthalmology; Carretera de Colmenar Viejo Km 9,100 Madrid Spain 28034"},{"name":"Universidad de Alcal\u00e1; Department of Surgery, School of Medicine; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"L\u00f3pez-Alcalde","sequence":"additional","affiliation":[{"name":"La\u00edn Entralgo Agency (Cochrane Collaborating Centre); Health Technology Assessment Unit; Gran V\u00eda 27, 7\u00aa Planta Madrid Madrid Spain 28013"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Morcillo Laiz","sequence":"additional","affiliation":[{"name":"Hospital Ram\u00f3n y Cajal; Department of Ophthalmology; Carretera de Colmenar Viejo Km 9,100 Madrid Spain 28034"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Fern\u00e1ndez Buenaga","sequence":"additional","affiliation":[{"name":"Hospital Ram\u00f3n y Cajal; Department of Ophthalmology; Carretera de Colmenar Viejo Km 9,100 Madrid Spain 28034"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Rebolleda Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Hospital Ram\u00f3n y Cajal; Department of Ophthalmology; Carretera de Colmenar Viejo Km 9,100 Madrid Spain 28034"},{"name":"Universidad de Alcal\u00e1; Department of Surgery, School of Medicine; Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD009078.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0002|cit2","first-page":"672","article-title":"A randomized, multi-center trial of topical cyclosporin 0.05% in steroid-resistant atopic keratoconjunctivitis","volume":"ARVO E-abstract","author":"Gottsch","year":"2003","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD009078.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD009078.pub2-BIB0004|cit4","first-page":"392","article-title":"The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis","volume":"40","author":"Hingorani","year":"1999","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"9","key":"10.1002\/14651858.CD009078.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD009078.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/ICO.0b013e318165692e","article-title":"Topical cyclosporin A in severe allergic conjunctivitis","volume":"27","author":"Bellini","year":"2008","journal-title":"Cornea"},{"issue":"4","key":"10.1002\/14651858.CD009078.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","article-title":"A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis","volume":"25","author":"Ebihara","year":"2009","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD009078.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00003226-199309000-00008","article-title":"Topical cyclosporin A in the treatment of anterior segment inflammatory disease","volume":"12","author":"Holland","year":"1993","journal-title":"Cornea"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0009|cit9","unstructured":"NCT00833495 Evaluation of efficacy of coadministration of FOV1101-00 and prednisolone acetate in patients with mild ongoing ocular allergic inflammation clinicaltrials.gov\/ct2\/show\/NCT00833495"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0010|cit10","unstructured":"NCT01120132 Study evaluating the efficacy of administration of cyclosporine (low dose and high dose) and prednisolone acetate compared to its components and vehicle in patients with allergic conjunctivitis clinicaltrials.gov\/ct2\/show\/NCT01120132"},{"issue":"4","key":"10.1002\/14651858.CD009078.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3129\/i09-117","article-title":"0.05% cyclosporine a for treatment of chronic severe ocular surface disease","volume":"44","author":"Nochez","year":"2009","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD009078.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/ICO.0b013e31812dfab3","article-title":"Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops","volume":"26","author":"Ozcan","year":"2007","journal-title":"Cornea"},{"issue":"7","key":"10.1002\/14651858.CD009078.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":"Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatric Allergy and Immunology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD009078.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1399-3038.2009.00948.x","article-title":"Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children","volume":"21","author":"Tesse","year":"2010","journal-title":"Pediatric Allergy and Immunology"},{"issue":"Pt B","key":"10.1002\/14651858.CD009078.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/978-1-4615-0717-8_114","article-title":"Topical cyclosporine A (2%) eyedrops in the therapy of atopic keratoconjunctivitis and keratoconjunctivitis vernalis","volume":"506","author":"Tomida","year":"2002","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0016|cit16","first-page":"3798","article-title":"Topic cyclosporine \"A\" in the management of allergic conjunctivitis","volume":"ARVO e-abstract","author":"Velasco","year":"2003","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0017|cit17","unstructured":"NCT00884585 Efficacy and safety study of cyclosporine 0.010% to treat atopic keratoconjunctivitis clinicaltrials.gov\/ct2\/show\/NCT00884585"},{"issue":"6","key":"10.1002\/14651858.CD009078.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0886-3350(00)00364-3","article-title":"Effect of topical anti-inflammatory drugs on corneal and limbal wound healing","volume":"26","author":"Barba","year":"2000","journal-title":"Journal of Cataract and Refractive Surgery"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0019|cit19","volume-title":"Blapharitis and Conjunctivitis. Guidelines for Diagnosis and Treatment","author":"BenEzra","year":"2006"},{"issue":"6","key":"10.1002\/14651858.CD009078.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal conjunctivitis revisited: a case series of 195 patients with long-term follow-up","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD009078.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archophthalmol.2008.608","article-title":"Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome","volume":"127","author":"Brown","year":"2009","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD009078.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/ACI.0b013e3282efd0bf","article-title":"Clinical grading of atopic keratoconjunctivitis","volume":"7","author":"Calonge","year":"2007","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD009078.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00130832-200410000-00016","article-title":"Developments in ocular allergy","volume":"4","author":"Chambless","year":"2004","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0024|cit24","unstructured":"Azuara-Blanco A Bunce C Burr J Dickersin K Diener-West M Elliott S Cochrane Eyes and Vision Group About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2010, Issue 1. Art. No.: EYES"},{"issue":"6560","key":"10.1002\/14651858.CD009078.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/bmj.293.6560.1477","article-title":"Eye disease at a community health centre","volume":"293","author":"Dart","year":"1986","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0026|cit26","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD009078.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0021-5155(98)00061-6","article-title":"Ocular surface disease in atopic dermatitis","volume":"43","author":"Dogru","year":"1999","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD009078.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(90)32477-6","article-title":"Atopic keratoconjunctivitis","volume":"97","author":"Foster","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0029|cit29","first-page":"1469","article-title":"Ocullar allergy","volume-title":"Allergy: Principles and Practice","author":"Friedlander","year":"1988"},{"issue":"6","key":"10.1002\/14651858.CD009078.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method improved on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD009078.pub2-BIB0031|cit31","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"2","key":"10.1002\/14651858.CD009078.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3163\/1536-5050.97.2.004","article-title":"Search strategies to identify information on adverse effects: a systematic review","volume":"97","author":"Golder","year":"2009","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0033|cit33","unstructured":"Green S Higgins J Glossary. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] www.cochrane.org\/resources\/handbook\/"},{"issue":"5","key":"10.1002\/14651858.CD009078.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/ACI.0b013e32833e16e4","article-title":"Atopic keratoconjunctivitis and atopic dermatitis","volume":"10","author":"Guglielmetti","year":"2010","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"7414","key":"10.1002\/14651858.CD009078.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0036|cit36","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0037|cit37","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD009078.pub2-BIB0038|cit38","first-page":"392","article-title":"The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis","volume":"40","author":"Hingorani","year":"1999","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0039|cit39","first-page":"265","article-title":"Atopic keratoconjunctivitis","volume":"50","author":"Hogan","year":"1952","journal-title":"Transactions of the American Ophthalmological Society"},{"issue":"6","key":"10.1002\/14651858.CD009078.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis","volume":"41","author":"Kili\u00e7","year":"2006","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD009078.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0002-9394(99)00295-0","article-title":"Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases","volume":"129","author":"Leonardi","year":"2000","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0042|cit42","unstructured":"Loke YK Price D Herxheimer A Chapter 14: Adverse effects In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD009078.pub2-BIB0043|cit43","first-page":"72","article-title":"Prevalence of allergic disease in Mexico city","volume":"56","author":"L\u00f3pez P\u00e9rez","year":"2009","journal-title":"Revista Alergia M\u00e9xico"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0044|cit44","volume-title":"Morbidity Statistics from General Practice. Fourth National Study 1991-2","author":"McCormick","year":"1995"},{"issue":"10","key":"10.1002\/14651858.CD009078.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/bjo.72.10.733","article-title":"How do general practitioner manage eye disease in the community?","volume":"72","author":"McDonnell","year":"1988","journal-title":"British Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD009078.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/bjo.82.8.971","article-title":"People and eyes: statistical approaches in ophthalmology","volume":"82","author":"Murdoch","year":"1998","journal-title":"British Journal of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD009078.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bjo.71.9.645","article-title":"Eyes or patients? Traps for the unwary in the statistical analysis of ophthalmological studies","volume":"71","author":"Newcombe","year":"1987","journal-title":"British Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD009078.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e3283303e2e","article-title":"Immune mechanisms in allergic eye diseases: what is new?","volume":"9","author":"Offiah","year":"2009","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD009078.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD009078.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0161-6420(98)94017-9","article-title":"Long-term follow-up of patients with atopic keratoconjunctivitis","volume":"105","author":"Power","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0051|cit51","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0052|cit52","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) Search filters for randomised controlled trials www.sign.ac.uk\/methodology\/filters.html#random"},{"key":"10.1002\/14651858.CD009078.pub2-BIB0053|cit53","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD009078.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2332\/allergolint.11-RAI-0335","article-title":"Japanese guideline for allergic conjunctival diseases","volume":"60","author":"Takamura","year":"2011","journal-title":"Allergology International"},{"issue":"2","key":"10.1002\/14651858.CD009078.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0161-6420(91)32322-4","article-title":"Clinical features of atopic keratoconjunctivitis","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD009078.pub2-BIB0056|cit56","first-page":"iii","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","journal-title":"Health Technology Assessment (Winchester, England)"},{"issue":"13","key":"10.1002\/14651858.CD009078.pub2-BIB0057|cit57","first-page":"2686","article-title":"Topical cyclosporine inhibits mast cell-mediated conjunctivitis","volume":"37","author":"Whitcup","year":"1996","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD009078.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.1995.tb02710.x","article-title":"Atopic retinal detachment. Report of four cases and review of the literature","volume":"133","author":"Yoneda","year":"1995","journal-title":"British Journal of Dermatology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009078.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:02:04Z","timestamp":1746529324000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009078.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009078.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}